A. V. D. Zee

Molecular prognostic markers in ovarian cancer: toward patient‐tailored therapy

E. D. de Vries, S. de Jong, A. Crijns, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Management of vulvar cancers.

J. D. de Hullu, A. van der Zee, I. V. D. van der Avoort, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.

H. Hollema, A. V. D. Van Der Zee, S. de Jong, 2014, Gynecologic oncology.

What doctors and patients think about false-negative sentinel lymph nodes in vulvar cancer

J. D. de Hullu, A. Ansink, T. Tymstra, 2001, Journal of psychosomatic obstetrics and gynaecology.

Volume-controlled versus short drainage after inguinofemoral lymphadenectomy in vulvar cancer patients: A Dutch nationwide prospective study.

K. Gaarenstroom, J. Velden, B. Slangen, 2017, Gynecologic oncology.

Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results.

V Ntziachristos, G. Themelis, H. Arts, 2011, Gynecologic oncology.